Form DEFA14A Bausch Health Companies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/26/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
Bausch Health Companies (BHC) PT Raised to $12 at RBC Capital
April 5, 2024 6:16 AM EDTRBC Capital analyst Doug Miehm raised the price target on Bausch Health Companies (NYSE: BHC) to $12.00 (from $9.00) while maintaining a Sector Perform rating.
The analyst comments "In the coming days/weeks, we expect the highly anticipated Xifaxan patent litigation ruling by the... More
